Abstract
To assess the role of dexamethasone treatment as a cause of systemic hypertension and associated complications, blood pressure was registered prospectively before, during and after a 4-week dexamethasone course in 22 neonates with chronic lung disease. In all patients systolic blood pressure rose significantly during treatment (median rise 34 mm Hg, range 4→59 mm Hg), without complications attributable to hypertension. In all but one patient blood pressure returned to pretreatment values within 2 weeks after stopping dexamethasone treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abman SH, Warady BA, Lum GM, Koops BL (1984) Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr 104: 928–931
Anand SK (1991) Hypertension. In: Taeusch HW, Ballard RA, Avery ME (eds) Diseases of the newborn. Saunders, London, p 906
Brozanski BS, Jones JG, Gilmour CH, Balsan MJ, Vazquez RL, Israel BA, Newman B, Mimouni FB, Guthrie RD (1995) Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr 126: 769–776
DeSwiet M, Fayers P, Shinebourne EA (1980) Systolic blood pressure in a population of infants in the first year of life: the Brompton study. Pediatrics 65: 1028–1035
Emery EF, Greenough A (1992) Effect of dexamethasone on blood pressure-relationship to postnatal age. Eur J Pediatr 151: 364–366
Fauser A, Pohlandt F, Bartmann P, Gortner L (1993) Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone. Eur J Pediatr 152: 354–356
Greenough A, Emery EF, Gamsu HR (1992) Dexamethasone and hypertension in preterm infants. Eur J Pediatr 151: 134–135
Harkavy KL, Scanlon JW, Chowdkry PK, Grylack LJ (1989) Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial. J Pediatr Der 115: 979–983
Hawkins KC, Watson AR, Rutter N (1995) Neonatal hypertension and cardiac failure. Eur J Pediatr 154: 148–149
Perlman JM, Volpe JJ (1989) Neurologic complications of captopril treatment of neonatal hypertension. Pediatrics 83: 47–52
Perlman JM, Moore V, Siegel MJ, Dawson J (1986) Is chloride depletion an important contributing cause of death in infants with bronchopulmonary dysplasia? Pediatrics 77: 212–216
Werner JC, Sicard RE, Hansen WR, Solomon E, Cowett RM, Oh W (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120: 286–291
Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS (1990) Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind controlled trial. J Pediatr 117: 273–282
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smets, K., Vanhaesebrouck, P. Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease. Eur J Pediatr 155, 573–575 (1996). https://doi.org/10.1007/BF01957907
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957907